Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. Research Outputs

Browsing by Author


Jump to:
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 166  next >
Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
201314-3-3ε Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular CarcinomaLiu T.-A.; Jan Y.-J.; BOR-SHENG KO ; Liang S.-M.; Chen S.-C.; Wang J.; CHIUN HSU ; YAO-MING WU ; Liou J.-Y.PLoS ONE5746
2013Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinomaYing-Chun Shen ; DA-LIANG OU ; CHIUN HSU ; Lin K.-L.; Chang C.-Y.; CHING-YU LIN ; Liu S.-H.; ANN-LII CHENG British Journal of Cancer140135
2010Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approachYing-Chun Shen ; CHIUN HSU ; Chen L.-T.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG Journal of Hepatology115110
2021Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic PerspectivesSu Y.-Y.; Li C.-C.; Lin Y.-J.; CHIUN HSU Seminars in Liver Disease88
1999Allogeneic stem cell transplantation for patients with high-risk myelodysplastic syndromeCHIUN HSU ; Lin M.-T.; JIH-LUH TANG ; HWEI-FANG TIEN ; Wang C.-H.; YAO-CHANG CHEN Journal of the Formosan Medical Association56
2011Antiangiogenic strategies for the treatment of hepatocellular carcinomaCHIUN HSU ; Ying-Chun Shen ; ANN-LII CHENG Targeted Therapies for Hepatocellular Carcinoma00
2007Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trialCHIA-CHI LIN ; CHIUN HSU ; CHIH-HUNG HSU ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HSIN YANG Investigational New Drugs9999
2022Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinomaLee, Jan-Mou; Hung, Yi-Ping; Chou, Kai-Yuan; Lee, Cheng-Yun; Lin, Shian-Ren; Tsai, Ya-Han; Lai, Wan-Yu; YU-YUN SHAO ; CHIUN HSU ; CHIH-HUNG HSU ; Chao, YeeFrontiers in medicine00
2022Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinomaYU-YUN SHAO ; HUNG-YANG KUO ; YUNG-MING JENG ; YAO-MING WU ; HSIU-PO WANG ; CHIUN HSU ; CHIH-HUNG HSU ; Hsu, Hey-Chi; ANN-LII CHENG ; ZHONG-ZHE LIN BMC cancer11
2020Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b studyLee M.S.; Ryoo B.-Y.; CHIH-HUNG HSU ; Numata K.; Stein S.; Verret W.; Hack S.P.; Spahn J.; Liu B.; Abdullah H.; Wang Y.; He A.R.; Lee K.-H.; Bang Y.-J.; Bendell J.; Chao Y.; Chen J.-S.; Chung H.C.; Davis S.L.; Dev A.; Gane E.; George B.; He A.R.; Hochster H.; CHIUN HSU ; Ikeda M.; Lee J.; Lee M.; Mahipal A.; Manji G.; Morimoto M.; Numata K.; Pishvaian M.; Qin S.; Ryan D.; Ryoo B.-Y.; Sasahira N.; Stein S.; Strickler J.; Tebbutt N.The Lancet Oncology246229
2009The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinomaZHONG-ZHE LIN ; Hsu H.-C.; CHIH-HUNG HSU ; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; SUNG-HSIN KUO ; CHIUN HSU ; Hu F.-C.; YUNG-MING JENG ; Chung Y.; ANN-LII CHENG Journal of Hepatology3839
2022AXL and MET in Hepatocellular Carcinoma: A Systematic Literature reviewCHIH-HUNG HSU ; Huang Y.-H.; Lin S.-M.; CHIUN HSU Liver Cancer11
2013Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II studyCHIH-HUNG HSU ; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN ; YU-YUN SHAO ; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; CHIUN HSU ; ANN-LII CHENG Oncology (Switzerland)3940
2009Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathwayChen K.-F.; Yeh P.-Y.; CHIUN HSU ; CHIH-HUNG HSU ; YEN-SHEN LU ; Hsieh H.-P.; PEI-JER CHEN ; ANN-LII CHENG Journal of Biological Chemistry8983
2010Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa BBOR-SHENG KO ; Chang T.-C.; Chen C.-H.; Liu C.-C.; Kuo C.-C.; CHIUN HSU ; Ying-Chun Shen ; Shen T.-L.; Golubovskaya V.M.; Chang C.-C.; Shyue S.-K.; Liou J.-Y.Life Sciences3936
2022Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic AdenocarcinomaSHIH-HUNG YANG ; JEN-CHIEH LEE ; BANG-BIN CHEN ; SUNG-HSIN KUO ; CHIUN HSU ; Bai, Li-YuanFrontiers in Immunology00
2006CD24 expression is a prognostic factor in intrahepatic cholangiocarcinomaSu M.-C.; CHIUN HSU ; Kao H.-L.; YUNG-MING JENG Cancer letters4744
2020Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinomaANN-LII CHENG ; CHIUN HSU ; Chan S.L.; Choo S.-P.; Kudo M.Journal of Hepatology188185
2000Chemotherapy alone versus, surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomachLiu H.-T.; CHIUN HSU ; Chen C.-L.; Chiang I.-P.; Chen L.-T.; YAO-CHANG CHEN ; ANN-LII CHENG American Journal of Hematology33
2014Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective studyCHIUN HSU ; Tsou H.-H.; Lin S.-J.; Wang M.-C.; MING YAO ; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.; Chang C.-S.; HWEI-FANG TIEN ; Liu T.-W.; PEI-JER CHEN ; ANN-LII CHENG Hepatology209192
Showing results 1 to 20 of 166  next >

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback